You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特朗普稱將削減藥價1,400%至1,500% 對藥品成本問題採取行動
美國總統特朗普表示,將削減藥價1,400%至1,500%,又稱會就美國藥品成本問題採取行動。有關言論確認美國政府對藥物定價的進取立場,以及計劃對進口藥品實施更高關稅。 特朗普早前向強生(JNJ.US)、輝瑞(PFE.US)、阿斯利康、百時美施貴寶(BMY.US)、葛蘭素史克、默少東(MRK.US)、諾和諾德、羅德藥廠及賽諾菲致函,要求有關藥企下月29日前減藥價,又要求有關樂企把最惠國待遇定價延伸至聯邦醫療補助病人。若企業不遵從,美國政府將動用所有手段保障美國家庭,免受持續的濫收藥費行為影響。他早前亦提出進口藥物關稅稅率最終將升至250%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account